No. 6: Satsuma Pharmaceuticals Inc. (STSA) Satsuma is a San Francisco-based pharmaceutical firm developing a dry-powder nasal spray to treat migraines. The product candidate — STS101 — can be quickly self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company began a Phase 3 electronic medical records and genomics (eMERGE) trial for STS101 this […]
Read MoreTrade Setup Buy Target – $2.70 or better Sell Target – TradersPro Sell Signal Generex Biotechnology Corporation, through its subsidiaries, primarily engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an insulin formulation administered as […]
Read MorePlus, Paul Singer’s Elliott Management just took a new stake in AT&T, Apple will announce new iPhones tomorrow, and shares of Chipotle are climbing.
Read MoreThere are a lot of factors that a smart investor should consider when thinking about using a stock for a long-term investing opportunity. A company’s fundamental strength and relative value are two of the primary elements that I pay attention to, but along with those I also factor in technical factors like the stock’s long-term […]
Read More